Wolff Benjamin G
Director
9 filings on record here, covering GSAT, UFPI, APP, IBCP, TCBK, CNXU, ARQT, CBKM and others. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-12
| Sell | GSAT | Globalstar, Inc. | $2,004,910 |
| Sell | GSAT | Globalstar, Inc. | $2,721,071 |
CORPORATEFiled 2026-08-04
| Award | UFPI | UFP INDUSTRIES INC | $33,738 |
CORPORATEFiled 2026-07-08
| Sell | APP | AppLovin Corp | $196,175 |
| Sell | APP | AppLovin Corp | $104,472 |
| Sell | APP | AppLovin Corp | $94,391 |
| Sell | APP | AppLovin Corp | $124,694 |
| Sell | APP | AppLovin Corp | $71,843 |
| Sell | APP | AppLovin Corp | $62,579 |
| Sell | APP | AppLovin Corp | $215,237 |
| Sell | APP | AppLovin Corp | $596,779 |
| Sell | APP | AppLovin Corp | $137,319 |
CORPORATEFiled 2026-07-02
| Award | IBCP | INDEPENDENT BANK CORP /MI/ | $80 |
| Award | IBCP | INDEPENDENT BANK CORP /MI/ | $4,447 |
CORPORATEFiled 2026-06-29
| Exercise | TCBK | TRICO BANCSHARES / | |
| Tax | TCBK | TRICO BANCSHARES / | $195,939 |
| Exercise | TCBK | TRICO BANCSHARES / | |
CORPORATEFiled 2026-06-22
| Exercise | CNXU | Conexeu Sciences Inc. | $250 |
| Exercise | CNXU | Conexeu Sciences Inc. | |
CORPORATEFiled 2026-06-17
| Exercise | ARQT | Arcutis Biotherapeutics, Inc. | $5,361 |
| Exercise | ARQT | Arcutis Biotherapeutics, Inc. | $7,653 |
| Exercise | ARQT | Arcutis Biotherapeutics, Inc. | $19,461 |
| Sell | ARQT | Arcutis Biotherapeutics, Inc. | $99,980 |
| Sell | ARQT | Arcutis Biotherapeutics, Inc. | $16,300 |
| Exercise | ARQT | Arcutis Biotherapeutics, Inc. | |
| Exercise | ARQT | Arcutis Biotherapeutics, Inc. | |
| Exercise | ARQT | Arcutis Biotherapeutics, Inc. | |
CORPORATEFiled 2026-06-15
| Buy | CBKM | CONSUMERS BANCORP INC /OH/ | $2,944 |
CORPORATEFiled 2026-06-12
| Award | PCRX | Pacira BioSciences, Inc. | |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.